Polyclonal VDAC3 antibody decreases human sperm motility: a novel approach to male contraception.

Asmarinah, Asmarinah; Saleh, Muhammad I; Wanandi, Septelia I; Narita, Vanny; Damayanti, Rita; Moeloek, Nukman H; Freisleben, H Joachim; Hinsch, Elvira.
Artículo en Inglés | IMSEAR | ID: sea-148862

Documentos relacionados

  1. Women's empowerment indicators and short- and long-acting contraceptive method use: evidence from DHS from 11 countries.
  2. [Male contraception: what are the currently available options?]
  3. [Acceptability of innovative male contraceptive methods among major of age heterosexual adult men in France in 2021].
  4. A prospective observational study of the effects of sugammadex on peri-operative oestrogen and progesterone levels in women who take hormonal contraception.
  5. The urgent need for innovation in contraception.
  6. [Predictor variables of contraceptive method use in young people: A systematic review].
  7. Access to on-campus contraception on college and university campuses in North Carolina.
  8. [State of contraception in 2016].
  9. Understanding adolescent girls' experiences with accessing and using contraceptives in Zambia.
  10. Impact of female contraception for population management on behavior and social interactions in a captive troop of Guinea baboons (Papio papio).